Evogene Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.43

+0.04 (+10.93%)

As of Jun 29, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,907.0% upside

Low Target $19.68

Average Target $21.60

High Target $29.43

Current Price $0.43

Current
$0.43

Target
$21.60

$19.68 $21.60 avg $29.43

Scenario Analysis

Bear Case

$19.68

4,461.9%

Low target

Base Case

$21.60

+4,907.0%

Avg target

Bull Case

$29.43

+6,722.0%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$1.50

-71.2% from high

52-Week Low

$0.38

+13.0% from low

Target vs 52W High

$21.60

+1,340.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%